BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9033228)

  • 1. Zidovudine and interferon therapy for adult T-cell leukaemia/lymphoma. Results of a preliminary study at UHWI-Mona.
    Wharfe G; Hanchard B
    West Indian Med J; 1996 Dec; 45(4):107-9. PubMed ID: 9033228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
    Hermine O; Allard I; Lévy V; Arnulf B; Gessain A; Bazarbachi A;
    Hematol J; 2002; 3(6):276-82. PubMed ID: 12522449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy.
    Aouba A; Lambotte O; Vasiliu V; Divine M; Valensi F; Varet B; Bazarbachi A; Hermine O
    Am J Hematol; 2004 Jun; 76(2):187-9. PubMed ID: 15164389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years.
    Bittencourt AL; Barbosa HS; Pimenta A; Farre L
    Acta Oncol; 2008; 47(5):981-3. PubMed ID: 18568490
    [No Abstract]   [Full Text] [Related]  

  • 5. AZT plus 3TC produces best results to date.
    Grodeck B
    Posit Aware; 1995; ():6. PubMed ID: 11362209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine (3TC) approved for combination use with AZT.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACTG 175 and Delta.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [With interferon and zidovudine against therapy refractory T-cell leukemias].
    Sauer H
    Fortschr Med; 1995 Dec; 113(34):8. PubMed ID: 8575716
    [No Abstract]   [Full Text] [Related]  

  • 11. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma.
    Pagano JS
    N Engl J Med; 1995 Nov; 333(19):1285-6. PubMed ID: 7566010
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. Lymphoma Study Group of the Japan Clinical Oncology Group.
    Tobinai K; Kobayashi Y; Shimoyama M
    N Engl J Med; 1995 Nov; 333(19):1285; author reply 1286. PubMed ID: 7566009
    [No Abstract]   [Full Text] [Related]  

  • 16. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
    Mildvan D; Bassiakos Y; Zucker ML; Hyslop N; Krown SE; Sacks HS; Zachary J; Paredes J; Fessel WJ; Rhame F; Kramer F; Fischl MA; Poiesz B; Wood K; Ruprecht RM; Kim J; Grossberg SE; Kasdan P; Bergé P; Marshak A; Pettinelli C
    Antivir Ther; 1996 Apr; 1(2):77-88. PubMed ID: 11321183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
    Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H
    Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.